Results 191 to 200 of about 73,761 (306)

Dupilumab‐Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay Registry

open access: yesClinical &Experimental Allergy, EarlyView.
DAOSD occurred in 34.6% of dupilumab‐treated paediatric AD patients, of which 30.6% required ocular anti‐inflammatory therapy. This high incidence rate underscores the importance of awareness during dupilumab treatment in paediatric patients. Elevated baseline serum IgE levels (≥ 3000 kU/L) may predict DAOSD development in paediatric AD patients ...
Lisa P. van der Rijst   +6 more
wiley   +1 more source

Inhibition of Tacrolimus Metabolism by Cannabidiol and Its Metabolites In Vitro. [PDF]

open access: yesClin Transl Sci
So GC   +8 more
europepmc   +1 more source

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

open access: yesClinical and Experimental Neuroimmunology, EarlyView.
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara   +5 more
wiley   +1 more source

Five-year experience with tacrolimus rescue for renal allograft rejection [PDF]

open access: green, 1997
Mark L. Jordan   +12 more
openalex   +1 more source

Real‐world safety and treatment patterns of subcutaneous IgPro20 for chronic inflammatory demyelinating polyneuropathy: Post‐marketing surveillance in Japan

open access: yesClinical and Experimental Neuroimmunology, EarlyView.
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka   +4 more
wiley   +1 more source

Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy